Application of Psoralca corylifolia in anti-infection of helicobacter pyloric and treating relative diseases
Patent Information
- Authority / Receiving Office
- CN · China
- Patent Type
- Patents(China)
- Current Assignee / Owner
- SHANGHAI INST OF MATERIA MEDICA CHINESE ACAD OF SCI
- Publication Date
- 2006-05-10
- Estimated Expiration
- Not applicable · inactive patent
Smart Images
Figure 1 Figure 2 Figure 3
Abstract
Description
Technical field
[0001] The present invention relates to new uses of traditional Chinese medicines, in particular to the application of psoralen and its extracts in resisting Helicobacter pylori infection and treating diseases related to Helicobacter pylori infection. Background technique
[0002] Chronic active gastritis, gastric ulcer and duodenal ulcer, gastric MALT lymphoma and gastric cancer are diseases that seriously endanger human health and life. Medical research has confirmed that the above diseases are all related to Helicobacter pylori (Hp) infection. Statistics show that more than 50% of the world’s population is infected with Helicobacter pylori, especially in developing countries. The infection rate of Helicobacter pylori in adults reaches 60-80%. In 1994, the International Agency for Research on Cancer (IARC) listed Hp as a Class I human carcinogen. At present, the combination of anti-endocrine drugs and antibiotics is used to treat H. pylori infection at home and ...